Section 460. Pharmaceutical and Therapeutics Committee.--(a) Any Commonwealth pharmacy program that establishes or maintains a preferred drug list for the purpose of receiving supplemental rebates consistent with section 1927(d)(4) of the Social Security Act (49 Stat. 620, 42 U.S.C. § 1396r-8(d)(4)) shall establish a pharmaceutical and therapeutics committee that shall serve in an advisory capacity to the department and to the secretary for the purpose of developing and maintaining a preferred drug list.
(b) The committee shall publicize its meetings pursuant to 65 Pa.C.S. Ch. 7 (relating to open meetings). The committee's deliberations, recommendations and decisions shall be open to the public except as limited by 65 Pa.C.S. §§ 707 (relating to exceptions to open meetings) and 708 (relating to executive sessions).
(c) The committee shall be comprised of the following members:
(1) Two individuals representing community pharmacists appointed by the secretary.
(2) Physicians, pharmacists and other members appointed by the secretary as needed to develop and maintain a preferred drug list.
((c) added Nov. 25, 2020, P.L.1213, No.121)
(460 amended July 4, 2008, P.L.557, No.44)